Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 04 2023
Historique:
pmc-release: 16 02 2024
medline: 24 4 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Glaucoma can develop following cataract removal in children. To assess the cumulative incidence of glaucoma-related adverse events (defined as glaucoma or glaucoma suspect) and factors associated with risk of these adverse events in the first 5 years after lensectomy prior to 13 years of age. This cohort study used longitudinal registry data collected at enrollment and annually for 5 years from 45 institutional and 16 community sites. Participants were children aged 12 years or younger with at least 1 office visit after lensectomy from June 2012 to July 2015. Data were analyzed from February through December 2022. Usual clinical care after lensectomy. The main outcomes were cumulative incidence of glaucoma-related adverse events and baseline factors associated with risk of these adverse events. The study included 810 children (1049 eyes); 443 eyes of 321 children (55% female; mean [SD] age, 0.89 [1.97] years) were aphakic after lensectomy, and 606 eyes of 489 children (53% male; mean [SD] age, 5.65 [3.32] years) were pseudophakic. The 5-year cumulative incidence of glaucoma-related adverse events was 29% (95% CI, 25%-34%) in 443 eyes with aphakia and 7% (95% CI, 5%-9%) in 606 eyes with pseudophakia; 7% (95% CI, 5%-10%) of aphakic eyes and 3% (95% CI, 2%-5%) of pseudophakic eyes were diagnosed as glaucoma suspect. Among aphakic eyes, a higher risk for glaucoma-related adverse events was associated with 4 of 8 factors, including age less than 3 months (vs ≥3 months: adjusted hazard ratio [aHR], 2.88; 99% CI, 1.57-5.23), abnormal anterior segment (vs normal: aHR, 2.88; 99% CI, 1.56-5.30), intraoperative complications at time of lensectomy (vs none; aHR, 2.25; 99% CI, 1.04-4.87), and bilaterality (vs unilaterality: aHR, 1.88; 99% CI, 1.02-3.48). Neither of the 2 factors evaluated for pseudophakic eyes, laterality and anterior vitrectomy, were associated with risk of glaucoma-related adverse events. In this cohort study, glaucoma-related adverse events were common after cataract surgery in children; age less than 3 months at surgery was associated with elevated risk of the adverse events in aphakic eyes. Children with pseudophakia, who were older at surgery, less frequently developed a glaucoma-related adverse event within 5 years of lensectomy. The findings suggest that ongoing monitoring for the development of glaucoma is needed after lensectomy at any age.

Identifiants

pubmed: 36795393
pii: 2801365
doi: 10.1001/jamaophthalmol.2022.6413
pmc: PMC9936384
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

324-331

Investigateurs

David K Wallace (DK)
Laura B Enyedi (LB)
Sasapin Prakalapakorn (S)
Sarah K Jones (SK)
Denise Hug (D)
Erin D Stahl (ED)
Rebecca J Dent (RJ)
Lingkun Kong (L)
Serena Wang (S)
Bryan K Gallerson (BK)
Amy K Hutchinson (AK)
Phoebe Lenhart (P)
Judy Brower (J)
David G Morrison (DG)
Scott T Ruark (ST)
Rebecca Mets-Halgrimson (R)
Hawke Yoon (H)
Hantamalala Ralay-Ranaivo (H)
Aaliyah Hamidullah (A)
Raymond Areaux (R)
Jill S Anderson (JS)
Ann M Holleschau (AM)
Rosanne Superstein (R)
Caroline Belanger (C)
Nicole Fallaha (N)
Patrick Hamel (P)
Maryse Thibeault (M)
Susanna M Tamkins (SM)
Ta Chang (T)
Hee-Jung S Park (HS)
Anya A Trumler (AA)
Xiaonong Liu (X)
Emi N Sanders (EN)
Elias Traboulsi (E)
Fatema Ghasia (F)
Diana C McOwen (DC)
Michael E Gray (ME)
Michael B Yang (MB)
Corey S Bowman (CS)
Jennifer Galvin (J)
Margaret Therriault (M)
Heather Smith (H)
Michele E Whitaker (ME)
Faruk Orge (F)
Adriana P Grigorian (AP)
Alicia M Baird (AM)
Mitchell B Strominger (MB)
Vicki Chen (V)
Shelley Klein (S)
Jacquelyn D Kemmer (JD)
Alexandra E Neiman (AE)
Myra N Mendoza (MN)
Jill J Frohwein (JJ)
Don Bremer (D)
Cybil Cassady (C)
Richard Golden (R)
Catherine Jordan (C)
David Rogers (D)
Sara A Oravec (SA)
Tammy L Yanovitch (TL)
Keven Lunsford (K)
Christina Nye (C)
Caroline Shea (C)
SueAnn M Stillman (SM)
G Robert LaRoche (GR)
Stephen C Van Iderstine (SC)
Elisa Robertson (E)
Oscar A Cruz (OA)
Rafif Ghadban (R)
Dawn Govreau (D)
Scott A Larson (SA)
Susannah Longmuir (S)
Xiaoyan Shan (X)
Michael P Clarke (MP)
Kate Taylor (K)
Christine Powell (C)
Benjamin P Hammond (BP)
Matthew D Gearinger (MD)
Andrea Czubinski (A)
Dorothy H Hendricks (DH)
Jing Jin (J)
Jonathan H Salvin (JH)
Alicia Fisher (A)
Katherine A Lee (KA)
Daniel Brooks (D)
Bonita R Schweinler (BR)
Nicholas A Sala (NA)
Allyson M Sala (AM)
Allison I Summers (AI)
Daniel J Karr (DJ)
Lorri B Wilson (LB)
Paula K Rauch (PK)
Mary O'Hara (M)
Nandini Gandhi (N)
Tania Hashmi (T)
Jeffrey Colburn (J)
Eileen Dittman (E)
Charles R Whitfill (CR)
Amy M Wheeler (AM)
Emily A McCourt (EA)
Jasleen Singh (J)
Nanastasia Welnick (N)
Nathalie F Azar (NF)
Joseph Baker (J)
Patrick J Droste (PJ)
Robert J Peters (RJ)
Jan Hilbrands (J)
Stacy L Pineles (SL)
Marianne J Bernardo (MJ)
Edward Peterson (E)
Charla H Peterson (CH)
Kartik Kumar (K)
Ephrem Melese (E)
Robert Lingua (R)
Jeff Grijalva (J)
Earl R Crouch (ER)
Earl R Crouch (ER)
Gaylord Ventura (G)
William Anninger (W)
Shawn L Benson (SL)
Karen A Karp (KA)
Jordana M Smith (JM)
Jill Brickman-Kelleher (J)
Benjamin H Ticho (BH)
Alexander J Khammar (AJ)
Deborah A Clausius (DA)
Suquin Guo (S)
Donny Suh (D)
Carolyn Chamberlain (C)
Susan Schloff (S)
William P Madigan (WP)
Donna Burkman (D)
Stephen P Christiansen (SP)
Jean E Ramsey (JE)
Kate H McConnell (KH)
Ilana Friedman (I)
Jose Rosado (J)
Donald P Sauberan (DP)
Jody C Hemberger (JC)
Patricia L Davis (PL)
Indre Rudaitis (I)
Robert S Lowery (RS)
Shawn Cupit (S)
Brian G Mohney (BG)
Suzanne M Wernimont (SM)
Rebecca A Neilsen (RA)
Erin P Herlihy (EP)
Francine Baran (F)
Amy Gladstone (A)
Justin Smith (J)
Mei Mellott (M)
Troy Kieser (T)
S Ayse Erzurum (SA)
Beth Colon (B)
Birva Shah (B)
Micaela Quebbemann (M)
Roy W Beck (RW)
Darrell S Austin (DS)
Nicole M Boyle (NM)
Courtney L Conner (CL)
Danielle L Chandler (DL)
Quayleen Donahue (Q)
Brooke P Fimbel (BP)
Julianne L Robinson (JL)
Amra Hercinovic (A)
James E Hoepner (JE)
Joseph D Kaplon (JD)
Robert J Henderson (RJ)
B Michele Melia (BM)
Gillaine Ortiz (G)
Victoria C Woodard (VC)
Kathleen M Stutz (KM)
Desirae R Sutherland (DR)
Donald F Everett (DF)
Marie Diener-West (M)
John D Baker (JD)
Barry Davis (B)
Dale L Phelps (DL)
Stephen W Poff (SW)
Richard A Saunders (RA)
Lawrence Tychsen (L)
Yasmin S Bradfield (YS)
Nicole C Foster (NC)
David A Plager (DA)
Daniel J Salchow (DJ)
Eileen E Birch (EE)
Ruth E Manny (RE)
Jayne L Silver (JL)
Katherine K Weise (KK)
Lisa C Verderber (LC)
Trevano W Dean (TW)
Kimberly G Yen (KG)
Alejandra G de Alba Campomanes (AG)
Marielle P Young (MP)
Bahram Rahmani (B)
Kathryn M Haider (KM)
George F Whitehead (GF)
Scott R Lambert (SR)
Sudhi P Kurup (SP)
Courtney L Kraus (CL)

Commentaires et corrections

Type : CommentIn

Auteurs

Erick D Bothun (ED)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Michael X Repka (MX)

Wilmer Eye Institute, Baltimore, Maryland.

Raymond T Kraker (RT)

Jaeb Center for Health Research, Tampa, Florida.

Rui Wu (R)

Jaeb Center for Health Research, Tampa, Florida.

David A Leske (DA)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Sarah R Hatt (SR)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Zhuokai Li (Z)

Jaeb Center for Health Research, Tampa, Florida.

Sharon F Freedman (SF)

Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.

William F Astle (WF)

Pediatric Ophthalmology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Susan A Cotter (SA)

Southern California College of Optometry at Marshall B. Ketchum University, Fullerton.

Jonathan M Holmes (JM)

Department of Ophthalmology and Vision Science, The University of Arizona, Tucson.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH